Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

The effect of lamotrigine on platelet serotonin concentration in patients with bipolar depression.

Sagud M, Pivac N, Mustapic M, Nedic G, Peles AM, Kramaric M, Jakovljevic M, Muck-Seler D.

Psychopharmacology (Berl). 2008 May;197(4):683-5. doi: 10.1007/s00213-008-1074-2. Epub 2008 Feb 2. No abstract available.

PMID:
18246328
2.

Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.

van der Loos ML, Mulder P, Hartong EG, Blom MB, Vergouwen AC, van Noorden MS, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

Bipolar Disord. 2011 Feb;13(1):111-7. doi: 10.1111/j.1399-5618.2011.00887.x.

PMID:
21320258
3.

Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.

van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

J Clin Psychiatry. 2009 Feb;70(2):223-31. Epub 2008 Dec 30.

PMID:
19200421
4.

International Consensus Group on the evidence-based pharmacologic treatment of bipolar I and II depression.

[No authors listed]

J Clin Psychiatry. 2008 Oct;69(10):1632-46. No abstract available.

PMID:
19192447
5.

Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine.

van der Loos ML, Mulder P, Hartong EG, Blom MB, Vergouwen AC, van Noorden MS, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

Acta Psychiatr Scand. 2010 Sep;122(3):246-54. doi: 10.1111/j.1600-0447.2009.01537.x. Epub 2010 Feb 5.

PMID:
20136801
6.

A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.

Barbee JG, Thompson TR, Jamhour NJ, Stewart JW, Conrad EJ, Reimherr FW, Thompson PM, Shelton RC.

J Clin Psychiatry. 2011 Oct;72(10):1405-12. doi: 10.4088/JCP.09m05355gre.

PMID:
21367355
7.

Lamotrigine combined with divalproex or lithium for bipolar disorder: a case series.

Redmond JR, Jamison KL, Bowden CL.

CNS Spectr. 2006 Dec;11(12):915-8.

PMID:
17146405
8.

Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.

Nierenberg AA, Ostacher MJ, Calabrese JR, Ketter TA, Marangell LB, Miklowitz DJ, Miyahara S, Bauer MS, Thase ME, Wisniewski SR, Sachs GS.

Am J Psychiatry. 2006 Feb;163(2):210-6.

PMID:
16449473
9.

Comments on "Addition of lamotrigine to valproic acid: a successful outcome in a case of rapid-cycling bipolar affective disorder".

Pae CU, Han C, Marks DM, Patkar AA.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):595-6. Epub 2007 Oct 25. No abstract available.

PMID:
18061327
10.

Lamotrigine-induced severe manic switch.

Desarkar P, Sinha VK.

Aust N Z J Psychiatry. 2006 Aug;40(8):718. No abstract available.

PMID:
16866770
11.

A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression.

Suppes T, Marangell LB, Bernstein IH, Kelly DI, Fischer EG, Zboyan HA, Snow DE, Martinez M, Al Jurdi R, Shivakumar G, Sureddi S, Gonzalez R.

J Affect Disord. 2008 Dec;111(2-3):334-43. doi: 10.1016/j.jad.2008.02.004. Epub 2008 Mar 20.

12.

A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.

Vieta E, Martinez-Arán A, Goikolea JM, Torrent C, Colom F, Benabarre A, Reinares M.

J Clin Psychiatry. 2002 Jun;63(6):508-12.

PMID:
12088162
13.

A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.

McElroy SL, Zarate CA, Cookson J, Suppes T, Huffman RF, Greene P, Ascher J.

J Clin Psychiatry. 2004 Feb;65(2):204-10.

PMID:
15003074
14.

Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.

Morishita S, Arita S.

Eur Psychiatry. 2003 Dec;18(8):418-20. No abstract available.

PMID:
14680720
15.

Assessment of medication adherence in a cohort of patients with bipolar disorder.

González-Pinto A, Reed C, Novick D, Bertsch J, Haro JM.

Pharmacopsychiatry. 2010 Nov;43(7):263-70. doi: 10.1055/s-0030-1263169. Epub 2010 Sep 14.

PMID:
20842617
16.

Open-label, concomitant use of lamotrigine and other medications for bipolar disorder.

Bowden CL, Edwards S, Evoniuk G.

CNS Spectr. 2008 Jan;13(1):75-83.

PMID:
18204417
17.

An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder.

Kessing LV, Hellmund G, Andersen PK.

J Psychopharmacol. 2012 May;26(5):644-52. doi: 10.1177/0269881111414091. Epub 2011 Sep 24.

PMID:
21948935
18.
19.

[Lithium and anticonvulsants in bipolar depression].

Samalin L, Nourry A, Llorca PM.

Encephale. 2011 Dec;37 Suppl 3:S203-8. doi: 10.1016/S0013-7006(11)70054-9. Review. French.

PMID:
22212876
20.

Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.

Solmi M, Veronese N, Zaninotto L, van der Loos ML, Gao K, Schaffer A, Reis C, Normann C, Anghelescu IG, Correll CU.

CNS Spectr. 2016 Oct;21(5):403-418.

PMID:
27686028

Supplemental Content

Support Center